Released on = January 22, 2007, 10:10 am

Press Release Author = Albert Hong

Industry = Biotech

Press Release Summary = In the October 17, 2006 issue of Biochemistry, researchers
performed a study that characterized the oligomerization and seeding capacity of
pGlu-amyloid peptides.

Press Release Body = Their results identified pGlu-modified beta-amyloid peptides as
displaying "up to 250-fold accelerated initial formation of aggregates compared to
unmodified Abeta"1, adding further support to the idea that pGlu-amyloid peptides
possess "biophysical characteristics that might be in particular crucial for the
initiation of [Alzheimer's disease]1." AnaSpec was one of the primary sources for
the peptides used in this study.

For more information, visit www.anaspec.com

AnaSpec, Inc., located in San Jose, CA, is a leading provider of integrated
proteomics solutions to pharmaceutical, biotech, and academic research institutions
throughout the world. With a vision for innovation through synergy, AnaSpec focuses
on three core technologies: peptides, detection reagents, and combinatorial
chemistry.

References:
1. Schilling, S. et al Biochemistry 45, 12393 (2006)



Web Site = http://www.anaspec.com

Contact Details = 2149 O\'Toole Ave.
San Jose, CA 95131
Tel: 408-452-5055
Fax: 408-452-5059
info@anaspec.com
www.anaspec.com